SUMMARY:

• According to the NEJM “in participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight”.
• In the clinical study, participants were enrolled in an “intensive” behavioral study with 8 weeks low-calorie diet.
• Yet the media has led with “diabetes drug leads to major weight loss”.
• Will doctors inform patients?